Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling.
Matsumura
Noriomi
N
Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Mandai
Masaki
M
Okamoto
Takako
T
Yamaguchi
Ken
K
Yamamura
Shogo
S
Oura
Tomonori
T
Baba
Tsukasa
T
Hamanishi
Junzo
J
Kang
Hyun S
HS
Matsui
Shigeyuki
S
Mori
Seiichi
S
Murphy
Susan K
SK
Konishi
Ikuo
I
D018262:Adenocarcinoma, Clear Cell / Q000188:drug therapy* / Q000235:genetics*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000627:therapeutic use*; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D009536:Niacinamide / Q000031:analogs & derivatives; D020411:Oligonucleotide Array Sequence Analysis; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D010671:Phenylurea Compounds; D011725:Pyridines / Q000627:therapeutic use*; D000077157:Sorafenib; D023041:Xenograft Model Antitumor Assays
D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib